title: Synthetic approaches to the 2006 new drugs.
abstract: New drugs are introduced to the market every year and each individual drug represents a privileged structure for its biological target. In addition, these new chemical entities (NCEs) not only provide insights into molecular recognition, but also serve as drug-like leads for designing future new drugs. To these ends, this review covers the syntheses of 16 NCEs marketed in 2006.
authors.affiliation: Pfizer Inc, La Jolla, CA 92037, USA. Kevin.k.liu@pfizer.com
authors.forename: Kevin K-C
authors.initials: KK
authors.lastname: Liu
authors.forename: Subas M
authors.initials: SM
authors.lastname: Sakya
authors.forename: Jin
authors.initials: J
authors.lastname: Li
mesh_terms: D004364:Pharmaceutical Preparations / Q000138:chemical synthesis* / Q000145:classification
chemical_list: D004364:Pharmaceutical Preparations